Alan Collier - Endonovo Therapeutics Chairman

Mr. Alan Collier is Director, Chief Executive Officer, Interim Chief Financial Officer and Secretary of the Company Since March 2012. Mr. Collier has more than twenty years of experience in finance, telecommunications, and consumer products. Over the progression of his career, he has specialized in the development and financing of early stage, high growth, and acquisitive companies . He has structured, participated in, and completed numerous transactions including mergers and acquisitions, equity and debt placements, capital restructuring, joint venture development, and channel partner procurement. Additionally, Mr. Collier was a Senior Managing Director at MidMarket Securities, a FINRAregistered BrokerDealer. He is also the cofounder and a Managing Member of C2 Capital, LLC, which provides management consulting services to companies preparing to go public. Prior to joining MidMarket Securities, Mr. Collier was a Managing Director of Mosaic Capital and comanaged its Capital Markets Group at Mosaic Capital. He was previously a Vice President at Corporationrationrate Capital Group and Managing Director and CEO of Greenbridge Capital Group. He has held numerous board and executive positions throughout his career. since 2012.